# INDSWFTLAB share price, delivery % and history — Ind-Swift Laboratories Limited

> Delivery percentage for Ind-Swift Laboratories Limited (INDSWFTLAB) against its own history, with 7,123 sessions of split-adjusted NSE data from 1997 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/INDSWFTLAB

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 388.75 INR (-5.89% on the day), 2026-09-30
- Delivery: 46.99% of volume taken to demat (20-day average 39.25%)
- Volume: 8.05L shares, turnover ₹31.3Cr
- Relative volume: 1.03× of its own 20-day average

## Technicals

- RSI(14): 57.23
- ATR(14): 22.99
- SMA 50: 324.38, SMA 200: 187.71
- 52-week range: 87.15 – 424.75 (-8.48% from the high)

## Performance

- 1 week -4.02%, 1 month 6.54%, 3 months 88.51%
- 6 months 181.27%, 1 year 274.16%

## Delivery percentage

- Latest: 46.99% (2026-09-30)
- 20-day average: 39.25%
- 1-year average: 51.22%
- Percentile against its own history: 17th
- Range: 8% – 100% across 1,728 sessions with a reading

Over the last 20 sessions INDSWFTLAB settled 39.2% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 51.2%, so recent sessions are running 12.0 points lower than usual. The latest session ranks higher than 17% of the 1,728 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 3,380.6 crore
- P/E (TTM): 58.97 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 6.59 INR, split-adjusted to match the price series
- Revenue growth: 25.35% YoY, 12.76% QoQ
- Profit growth: 181.32% YoY, 63.34% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | -18.62% | -55.61% |
| 3y | -18.71% | 7.61% |
| 4y | -11.2% | — |
| 6y | -2.98% | — |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 12 | 24.4 | 0.6 | 0.4 | 0.07 | 3.46% |
| 2024-12-31 | 8.7 | 23.6 | -1.1 | 0 | 0 | 0.07% |
| 2025-03-31 | 138.2 | 128.1 | 230.5 | 222.3 | 32.96 | 160.79% |
| 2025-06-30 | 152.7 | 157 | 10.4 | 8.8 | 1.28 | 5.74% |
| 2025-09-30 | 152.6 | 160.2 | 10.3 | 8 | 1 | 5.23% |
| 2025-12-31 | 150.9 | 156.2 | 16.4 | 9.5 | 1.17 | 6.32% |
| 2026-03-31 | 169.8 | 154.9 | 12 | 15.1 | 1.81 | 8.9% |
| 2026-06-30 | 191.5 | 166.3 | 32.6 | 24.7 | 2.84 | 12.89% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 42.93%
- Public: 57.07%
- FII: 10.7%, DII: 0.17%
- Promoter shares pledged: 0%

## Recent filings

- 2026-08-10: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_184783_10082026195216_iXBRL_WEB.html
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697253_20072026061042_WEB.xml
- 2026-05-28: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_163201_28052026222020_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1656539_21042026061124_WEB.xml
- 2026-03-05: shareholding for 2026-02-24 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1632754_05032026060939_WEB.xml
- 2026-01-31: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_139595_31012026202119_iXBRL_WEB.html
- 2026-01-21: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1607173_21012026044427_WEB.xml
- 2025-11-14: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_128520_14112025215806_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 119 events are indexed for this instrument.

## About the instrument

- Listed: 1997-07-16 — latest session 2026-09-30 (7,123 sessions)
- ISIN: INE915B01019
- Series: EQ
- Liquidity rank: #629 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/INDSWFTLAB.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.